Pharscin Pharma's controlling shareholder's concerted action parties plan to reduce their holdings by no more than 3%
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Pharscin Pharma announced that the company recently received a notice from Mr. You Hongtao, a concerted actor of the controlling shareholder, and Shanghai Tiancheng Investment Management Co., Ltd. - Tiancheng Tianli No. 1 Private Securities Investment Fund (referred to as "Tiancheng Tianli No. 1 Fund") regarding the plan to reduce their holdings in the company. The total reduction plan will not exceed 12.5278 million shares, accounting for no more than 3% of the company's total share capital
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments